Pharmaceutical composition of melatonin and vitamin E and application thereof

The invention relates to a melatonin and vitamin E pharmaceutical composition and application thereof. According to the invention, the novel application of combination of melatonin and vitamin E in preparation of ovarian anti-radiation drugs or drugs for treating ovarian ionizing radiation injury is confirmed for the first time; animal models prove that the pharmaceutical composition disclosed by the invention can be used for improving the estrus cycle disorder of irradiated mice, increasing the ovarian organ coefficient of the irradiated mice, improving the mouse ovarian hormone level disorder caused by irradiation and increasing the number of irradiated mouse follicles. The melatonin and the vitamin E can be used for treating the radiation-induced ovarian tissue injury, and a new hope is brought to the prevention of the radiation injury of the ovary..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 23. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

CAI SHENGYUN [VerfasserIn]
YU YIKE [VerfasserIn]
XU MINGJUAN [VerfasserIn]
GUAN RUI [VerfasserIn]
XIA LEILEI [VerfasserIn]
YAN JIUQIONG [VerfasserIn]
LI LI [VerfasserIn]
LI BENDONG [VerfasserIn]
LIN FAN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-06-23, Last update posted on www.tib.eu: 2024-03-04, Last updated: 2024-03-08

Patentnummer:

CN116270618

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018101402